Practical Approach to Hyperandrogenism in Women.
Sharma A, Welt CK.
Med Clin North Am. 2021 Nov;105(6):1099-1116. doi: 10.1016/j.mcna.2021.06.008. Epub 2021 Sep 8.
Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism.
Armanini D, Boscaro M, Bordin L, Sabbadin C.
Int J Mol Sci. 2022 Apr 8;23(8):4110. doi: 10.3390/ijms23084110.
Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC.
Clin Chim Acta. 2020 Mar;502:214-221. doi: 10.1016/j.cca.2019.11.003. Epub 2019 Nov 13.
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL.
J Clin Endocrinol Metab. 2023 Apr 13;108(5):1243-1253. doi: 10.1210/clinem/dgac673.
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL, Ehrmann DA.
Endocr Rev. 2016 Oct;37(5):467-520. doi: 10.1210/er.2015-1104. Epub 2016 Jul 26.
Hyperandrogenism and Its Possible Effects on Endometrial Receptivity: A Review.
Yusuf ANM, Amri MF, Ugusman A, Hamid AA, Wahab NA, Mokhtar MH.
Int J Mol Sci. 2023 Jul 27;24(15):12026. doi: 10.3390/ijms241512026.
Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.
Zaman A, Rothman MS.
Endocrinol Metab Clin North Am. 2021 Mar;50(1):97-111. doi: 10.1016/j.ecl.2020.12.002. Epub 2021 Jan 11.
Postmenopausal hyperandrogenism.
Yoldemir T.
Climacteric. 2022 Apr;25(2):109-117. doi: 10.1080/13697137.2021.1915273. Epub 2021 May 14.
Hyperandrogenism after menopause.
Markopoulos MC, Kassi E, Alexandraki KI, Mastorakos G, Kaltsas G.
Eur J Endocrinol. 2015 Feb;172(2):R79-91. doi: 10.1530/EJE-14-0468. Epub 2014 Sep 15.
Gestational Hyperandrogenism in Developmental Programming.
Hakim C, Padmanabhan V, Vyas AK.
Endocrinology. 2017 Feb 1;158(2):199-212. doi: 10.1210/en.2016-1801.
